Every publically traded cell therapy company has been dropping in price. And this is happening as all get closer to finishing pivotal trials that point to positive results. Big money is finally investing in this sector and they want to invest as cheaply as they can. Big money has the tools to keep the stock price low..
Second big Pharma wants stock price low to make better deals and or to limit the ability to raise capital.
IMO Everything is reversed when investing in biotech. This is Bizarro world. Up is down and down is up.
Eventually the truth plays out.... Always takes longer than anyone expected.
Think the internet bubble.
Why the big drop?, page-15
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |